Transcatheter JenaValve Implantation in a Stentless Prosthesis: A Challenging Case After 4 Previous Aortic Procedures.
A 40-year-old man underwent 4 aortic surgeries because of endocarditis and subsequent prosthesis dehiscence. At the last recurrence he presented with acute severe aortic regurgitation of a Pericarbon Freedom (LivaNova plc, London, UK) stentless bioprosthesis and a morphologically disarranged aortic root. He also presented with left ventricular dysfunction and a very low origin of the left coronary artery. Therefore, a fifth redo aortic valve replacement was considered at high surgical risk. Accordingly, before listing the patient for a heart transplantation, a transcatheter valve-in-valve implantation with the JenaValve (JenaValve Technology, GmbH, Munich, Germany) prosthesis was performed.
Cardiothoracic Department, University Hospital of Udine, Udine, Italy. Electronic address: sandro_sponga@yahoo.com.
Sandro
S
Sponga
Cardiothoracic Department, University Hospital of Udine, Udine, Italy.
Enzo
E
Mazzaro
Division of Cardiology, Department of Medicine, London Health Sciences Center, Western University, London, Ontario, Canada.
Rodrigo
R
Bagur
Cardiothoracic Department, University Hospital of Udine, Udine, Italy.
Ugolino
U
Livi
D000208:Acute Disease; D000328:Adult; D001021:Aortic Valve / Q000601:surgery*; D001022:Aortic Valve Insufficiency / Q000175:diagnosis / Q000601:surgery*; D001705:Bioprosthesis; D017548:Echocardiography, Transesophageal; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D011474:Prosthesis Design; D012086:Reoperation; D015607:Stents; D065467:Transcatheter Aortic Valve Replacement / Q000379:methods*